Cover Image
市場調查報告書

全球核酸分離、煉製市場:市場規模,區分,市場佔有率,競爭情形

Global Nucleic Acid Isolation and Purification (NAIP) Market - Segmented by Technology, Application, Product, End-Users and Geography - Growth, Trends and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 367224
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球核酸分離、煉製市場:市場規模,區分,市場佔有率,競爭情形 Global Nucleic Acid Isolation and Purification (NAIP) Market - Segmented by Technology, Application, Product, End-Users and Geography - Growth, Trends and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 112 Pages
簡介

本報告提供全球核酸分離、煉製市場相關調查分析,市場概要,市場動態,各市場區隔分析,競爭情形等系統性資訊。

簡介

調查手法

摘要整理

主要的推論

市場概要與產業趨勢

  • 目前市場方案
  • 市場概要
  • 新的發展
  • 五力

推動因素、阻礙因素、機會、課題分析 (DROC)

  • 推動市場要素
  • 阻礙市場要素
  • 主要課題
  • 目前機會

全球核酸分離、煉製市場:各技術

  • 管柱
  • 電磁
  • 試劑

全球核酸分離、煉製市場:各產品

  • 消耗品
  • 試劑
  • 設備
  • 其他

全球核酸分離、煉製市場:各用途

  • RNA定序
  • RNA微陣列分析
  • RNA基因複製
  • DNA基因複製
  • DNA定序
  • DNA電泳
  • 轉錄分析
  • 其他

全球核酸分離、煉製市場:各終端用戶

  • 醫院
  • 大學
  • 醫藥品
  • 生物科技
  • CRO
  • 其他

全球核酸分離、煉製市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲

競爭情形

  • M&A分析
  • 新產品銷售
  • 契約、聯盟、夥伴關係

主要供應商分析

  • Agilen Technologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • GE Healthcare
  • Roche Applied Sciences
  • Sigma Aldrich
  • Life Technologies
  • Thermo Fisher Scientific
  • TaKaRa BIO

投資機會預測

市場未來發展預測

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 26198

The global nucleic acid isolation and purification (NAIP) market is estimated to reach approximately USD 5,300 million by 2023, at a CAGR of about 9% during the forecast period. This market is segmented based on technology, product, application, end user, and geography. In the segmentation based on technology, column-based purification has the largest market share, however, magnetic bead-based purification is expected to witness the highest CAGR.

Rise in R&D Funding in Biotechnology & Healthcare

Biotech and Pharma companies have a growing demand for pure nucleic acids. Pure nucleic acid is finding applications in emerging fields, like genetic engineering, molecular diagnosis, forensics, and research related to life sciences. Consequently, the governments have stepped up funding for R&D projects. The pharma sector has stepped up investments in products requiring NAIP Instruments, as NAIP technologies are becoming more prevalent now. Rise in automation has also stepped up NAIP applications.

Low Penetration in Emerging Countries

The availability of automation technology in emerging economies is very low. Automation technology is a major reason for rising applicability of NAIP technology. Low automation presents a problem in harnessing the full potential of NAIP technology. Companies would need to work out ways to increase the availability of automation technology in the developing regions. As the penetration of automation and NAIP technology is low in emerging economies, consequently the cost of automated instruments is also very high (higher than the base cost in developed countries). These hurdles of pricing and technology penetration are potential barriers for the market's growth.

North America to Dominate the Market Growth

North America has the largest market share and is expected to lead the market during the forecast period. Asia-Pacific is expected to witness the highest CAGR during the forecast period. Increasing use of kits in molecular diagnostics and rapid development of healthcare facilities in emerging economies are the key factors that justify the growth rate in Asia-Pacific.

Key Developments in the Market

July 2017: Life sciences tools provider, LGC, acquired Link Technologies, a supplier of specialty reagents for oligonucleotide synthesis. Following the acquisition, LGC plans to form a new Nucleic Acid Chemistry business unit within its Genomics division that combines Link with its existing Biosearch Oligo Reagent group and Prime Synthesis CPG business.

October 2017: Avalon GloboCare's majority-owned subsidiary, GenExosome Technologies, acquired 100% of the outstanding capital stock of a Chinese exosome technology company, called Beijing Jieteng (Beijing GenExosome) Biotech.

Major Players: AGILENT TECHNOLOGIES, BIO-RAD LABORATORIES, DANAHER CORPORATION, GE HEALTHCARE, ROCHE APPLIED SCIENCES, SIGMA ALDRICH, LIFE TECHNOLOGIES, THERMO FISHER SCIENTIFIC, TAKARA BIO INC., QIAGEN amongst others.

Reasons to Purchase this Report

Current and future nucleic acid isolation & purification market outlook in the developed and emerging markets.

Analyzing various perspectives of the market with the help of Porter's five forces analysis.

The segment that is expected to dominate the market.

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players.

3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threats of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Rapid Technological Advances Boosting the Market Growth
    • 6.1.2 Wide Range Applications of Nucleic Acid Testing in Diagnostics Boosting the Market
    • 6.1.3 Rise in the R&D Funding In Biotechnology & Healthcare
  • 6.2 Market Restraints
    • 6.2.1 Low Penetration in Emerging Markets
    • 6.2.2 Increasing Cost of Automated Instruments
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 Segmentation-By Technology
    • 7.1.1 Column Based Purification
    • 7.1.2 Magnetic Bead Based Purification
    • 7.1.3 Reagent Based Purification
  • 7.2 By Product
    • 7.2.1 Kits
    • 7.2.2 Reagents
    • 7.2.3 Equipment
    • 7.2.4 Others
  • 7.3 By Application
    • 7.3.1 RNA Sequencing
    • 7.3.2 RNA Microarray Analysis
    • 7.3.3 RNA Cloning
    • 7.3.4 DNA Cloning
    • 7.3.5 DNA Sequencing
    • 7.3.6 DNA Electrophoresis
    • 7.3.7 Trasncriptome Analysis
    • 7.3.8 Others
  • 7.4 By End Users
    • 7.4.1 Hospitals
    • 7.4.2 Academia
    • 7.4.3 Pharmaceuticals
    • 7.4.4 Biotechnology
    • 7.4.5 CRO
    • 7.4.6 Others
  • 7.5 Segmentation-By Geography
    • 7.5.1 North America
      • 7.5.1.1 US
      • 7.5.1.2 Canada
      • 7.5.1.3 Mexico
    • 7.5.2 Europe
      • 7.5.2.1 France
      • 7.5.2.2 Germany
      • 7.5.2.3 UK
      • 7.5.2.4 Italy
      • 7.5.2.5 Spain
      • 7.5.2.6 Rest of Europe (RoE)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China
      • 7.5.3.2 Japan
      • 7.5.3.3 India
      • 7.5.3.4 Australia & New Zealand
      • 7.5.3.5 South Korea
      • 7.5.3.6 Rest of Asia-Pacific
    • 7.5.4 Middle East & Africa
      • 7.5.4.1 GCC
      • 7.5.4.2 South Africa
      • 7.5.4.3 Rest of the Middle East & Africa
    • 7.5.5 South America
      • 7.5.5.1 Brazil
      • 7.5.5.2 Argentina
      • 7.5.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers & Acquisition Analysis
  • 8.2 Agreements, Collaborations & Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Agilent Technologies
  • 9.2 Bio-Rad Laboratories
  • 9.3 Danaher Corporation
  • 9.4 GE Healthcare
  • 9.5 Roche Applied Sciences
  • 9.6 Sigma Aldrich
  • 9.7 Life Technologies
  • 9.8 Thermo Fisher Scientific
  • 9.9 Takara Bio Inc.
  • 9.10 Others

10. Future of the Market

Back to Top